A federal agency buys advanced kits to pinpoint infections and drug resistance
What happened
A federal agency bought specialized kits from Illumina. These kits identify pathogens and their resistance to drugs using advanced genetic tools.
Why it matters
This purchase shows a federal agency is using advanced molecular diagnostics. These tools give more precise information than older lab methods. They can identify specific pathogens and their drug resistance faster. This helps doctors choose better treatments sooner.
The signal
Watch for other federal agencies to buy similar advanced diagnostic kits, especially for infectious diseases.